Clinical Trial

First-in-Human Single and Multiple Dose of KLA578-1 for Injection

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 26, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the safety and tolerability and pharmacokinetics of single and multiple doses of KLA578-1 for injection in healthy volunteers
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-19; most recent amendment 2026-05-21.
Trial Details
NCT Number NCT07143318
Lead Sponsor Hunan Kelun Pharmaceutical Co., Ltd.
Conditions Healthy Volunteers
Enrollment 48 participants
Start Date 2025-06-05
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-26